首页> 外文期刊>The Journal of Hip Surgery >Postoperative Doxycycline Did Not Improve Early Postoperative Outcomes in Hip Arthroscopy Patients: A Retrospective Cohort Study
【24h】

Postoperative Doxycycline Did Not Improve Early Postoperative Outcomes in Hip Arthroscopy Patients: A Retrospective Cohort Study

机译:术后多西环素未改善髋关节镜患者的早期术后结局:一项回顾性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Doxycycline has been shown to reduce fibroblast activity in the treatment of multiple pathologies, and was utilized as part of the postoperative medication protocol to help prevent adhesions from developing after hip arthroscopy. The purpose of this study was to compare early postoperative pain outcomes between consecutive case series of femoroacetabular impingement syndrome (FAIS) patients treated with or without a 7-day postoperative course of doxycycline following hip arthroscopy. We hypothesized that the doxycycline-treated group would have superior patient-reported outcomes at 6 weeks, and the effect would be more pronounced for patients with low preoperative mental health scores.Our institutional review board–approved prospective outcomes registry was queried for patients who had undergone arthroscopic femoral osteochondroplasty and/or labral repair or reconstruction secondary to FAIS performed by a single, fellowship-trained surgeon. A 7-day postoperative course of doxycycline was initiated in 2018. Six-week postoperative Hip Disability and Osteoarthritis Outcome Score (HOOS) global (HOOSglobal) and International Hip Outcome Tool (iHOT) scores were compared between the consecutive series treated with versus without doxycycline. Additional subgroup analysis was performed on patients with low preoperative Veterans RAND 12-Item Health Survey (VR-12) mental component scores to determine possible additional benefit of postoperative doxycycline in this group.A total of 134 patients (98 female, 36 male, age?=?36.2?±?13.4 years, body mass index [BMI]?=?27.2?±?5?kg/m2) were identified between 2013 and 2020. There were no differences between the control (n?=?84) and doxycycline group (n?=?50) in age, sex, or BMI. Postoperative HOOSglobal scores (control?=?58.5?±?13.1, doxycycline?=?58.7?±?14.7, p?=?0.96) and iHOT scores (control?=?54.4?±?22.2, doxycycline?=?52.3?±?24.8, p?=?0.61) did not differ between groups. The subset of 83 patients with low preoperative mental scores showed no differences in HOOSglobal (control?=?51.6?±?13.3, doxycycline?=?57.3?±?7.4, p?=?0.12) or iHOT scores (control?=?45.5?±?20.3, doxycycline?=?53.6?±?23.1, p?=?0.250).Our results do not support the hypothesis that postoperative doxycycline leads to significant improvement in early postoperative pain scores or functional outcomes in patients undergoing hip arthroscopy for FAIS.
机译:强力霉素已经被证明可以减少成纤维细胞治疗多种活动病态,并利用的一部分防止术后药物治疗协议臀部关节镜后粘连来自发展中。本研究的目的是比较早术后疼痛连续之间的结果一系列femoroacetabular撞击综合症患者(做)或没有术后7天的强力霉素后臀部关节镜检查。doxycycline-treated组优越patient-reported结果在6周,患者的效果会更明显术前心理健康得分较低。机构审查委员会批准了潜在结果注册表是查询病人经历了关节镜股osteochondroplasty和/或上唇的修复重建次要做执行的单身,训练的外科医生。术后的强力霉素是发起在2018年。和骨关节炎评分结果(hoo)全球(HOOSglobal)和国际时尚结果的工具(iHOT)分数之间的比较连续系列处理而没有强力霉素。对患者进行术前低退伍军人兰德12项健康调查(VR-12)分数来确定可能的心理组件术后强力霉素的附加好处在这一组。36岁男性,年龄吗? = 36.2 ?±13.4年,身体质量指数27.2 (BMI) = ? ?±? 5 ? kg / m2)之间被确定2013年和2020年。对照组(n = ? 84)和强力霉素组(n = ? 50)在年龄、性别、或BMI。强力霉素? = 58.7 ? 0.96±14.7,p ? = ? ?)和iHOT分数(控制? = 54.4 ?±? 22.2,强力霉素? = 52.3 ? 0.61±24.8,p ? = ? ?)没有不同组之间。术前心理较低分数没有显示差异HOOSglobal(控制? = 51.6 ?±? 13.3,强力霉素? = 57.3 ? 0.12±7.4,p ? = ? ?)或iHOT分数(控制? = 45.5 ?±? 20.3,强力霉素? = 53.6 ? 0.250±23.1,p ? = ? ?)。不支持的假设术后强力霉素导致显著的改善早期术后疼痛分数或功能结果患者接受髋关节关节镜检查“干什么”。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号